News
New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapiesCORALVILLE, Iowa ...
An easy method for efficiently identifying proteins that interact with bioactive molecules has been developed by chemical biologists at RIKEN. This innovation, published in ChemBioChem, could help to ...
What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have found a way to do just that—by tweaking a key molecule in the vaccine’s ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis continues the discussion on mRNA and srRNA ...
In multiple experiments, C-a16 lipids, which contain a phenol group, outperformed LNPs used in currently available mRNA ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...
Researchers at the University of Oxford and Nanyang Technological University, Singapore (NTU Singapore) have uncovered the mechanism by which cells identify and repair a highly toxic form of DNA ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris announced a collaboration with Thermo Fisher Scientific. The partnership ...
Scientists involved in the Synthetic Human Genome Project are now attempting to create a fully synthetic human chromosome, making up about two per cent of human DNA, as proof of concept.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results